Literature DB >> 35507038

Safety and Clinical Benefits of Laryngeal Closure in Patients with Amyotrophic Lateral Sclerosis.

Sayaka Yokoi1, Naoki Nishio2, Takashi Maruo1, Mariko Hiramatsu1, Nobuaki Mukoyama1, Hidenori Tsuzuki1, Akihisa Wada1, Naoki Atsuta3, Daisuke Ito4, Takashi Tsuboi4, Gen Sobue5, Masahisa Katsuno4, Yasushi Fujimoto1,6, Michihiko Sone1.   

Abstract

This study evaluated the safety of laryngeal closure and post-surgical changes in swallowing function of patients with amyotrophic lateral sclerosis (ALS) and proposed an appropriate surgical strategy for patients with ALS. Clinical and surgical data of 26 consecutive patients with ALS who underwent laryngeal closure at Nagoya University Hospital in Japan between 2003 and 2020 were retrospectively analyzed. Changes in swallowing functions were evaluated before and approximately 1 month post-surgery using Neuromuscular Disease Swallowing Status Scale (NdSSS), and Functional Oral Intake Scale (FOIS). The median operation time was 126 min (range, 51-163 min), and the median intraoperative blood loss was 20 mL (range, 0-88 mL). Among the 26 ALS patients who underwent laryngeal closure, grade 1 (mild) complications occurred in three patients (12%); however, no severe complications were observed. After surgery, 25 patients (96%) maintained the swallowing function and only one patient (4%) had deteriorating NdSSS and FOIS scores. No patients were referred to our hospital due to severe aspiration pneumonia after the surgery. Two patients did not require a feeding tube after the surgery and returned to oral intake. Laryngeal closure may be a safe surgical procedure for preventing chronic aspiration and may also maintain swallowing function of patients with ALS. Further multicenter prospective studies using the gold standard videofluoroscopic swallowing examination are required to support our findings.
© 2022. The Author(s).

Entities:  

Keywords:  Amyotrophic lateral sclerosis; Chronic aspiration; Clinical benefit; Laryngeal closure; Swallowing function

Year:  2022        PMID: 35507038     DOI: 10.1007/s00455-022-10454-0

Source DB:  PubMed          Journal:  Dysphagia        ISSN: 0179-051X            Impact factor:   3.438


  36 in total

1.  Reduction rate of body mass index predicts prognosis for survival in amyotrophic lateral sclerosis: a multicenter study in Japan.

Authors:  Toshio Shimizu; Utako Nagaoka; Yuki Nakayama; Akihiro Kawata; Chiharu Kugimoto; Yoshiyuki Kuroiwa; Mitsuru Kawai; Takayoshi Shimohata; Masatoyo Nishizawa; Ban Mihara; Hajime Arahata; Naoki Fujii; Reiko Namba; Hiroaki Ito; Takashi Imai; Keigo Nobukuni; Kiyohiko Kondo; Mieko Ogino; Takashi Nakajima; Tetsuo Komori
Journal:  Amyotroph Lateral Scler       Date:  2012-06

Review 2.  Energy metabolism in amyotrophic lateral sclerosis.

Authors:  Luc Dupuis; Pierre-François Pradat; Albert C Ludolph; Jean-Philippe Loeffler
Journal:  Lancet Neurol       Date:  2010-10-27       Impact factor: 44.182

3.  Laryngectomy for chronic aspiration.

Authors:  C R Cannon; W C McLean
Journal:  Am J Otolaryngol       Date:  1982 Mar-Apr       Impact factor: 1.808

4.  Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial.

Authors:  Anne-Marie Wills; Jane Hubbard; Eric A Macklin; Jonathan Glass; Rup Tandan; Ericka P Simpson; Benjamin Brooks; Deborah Gelinas; Hiroshi Mitsumoto; Tahseen Mozaffar; Gregory P Hanes; Shafeeq S Ladha; Terry Heiman-Patterson; Jonathan Katz; Jau-Shin Lou; Katy Mahoney; Daniela Grasso; Robert Lawson; Hong Yu; Merit Cudkowicz
Journal:  Lancet       Date:  2014-02-28       Impact factor: 79.321

5.  Diverting the paralyzed larynx: a reversible procedure for intractable aspiration.

Authors:  R C Lindeman
Journal:  Laryngoscope       Date:  1975-01       Impact factor: 3.325

Review 6.  Prognostic factors in ALS: A critical review.

Authors:  Adriano Chiò; Giancarlo Logroscino; Orla Hardiman; Robert Swingler; Douglas Mitchell; Ettore Beghi; Bryan G Traynor
Journal:  Amyotroph Lateral Scler       Date:  2009 Oct-Dec

7.  Dysphagia in inclusion body myositis.

Authors:  A R Wintzen; G T Bots; H M de Bakker; J H Hulshof; G W Padberg
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-12       Impact factor: 10.154

Review 8.  Management of dysphagia in inclusion body myositis.

Authors:  D H Darrow; H T Hoffman; G J Barnes; C A Wiley
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1992-03

9.  Defining Swallowing-Related Quality of Life Profiles in Individuals with Amyotrophic Lateral Sclerosis.

Authors:  Lauren Tabor; Joy Gaziano; Stephanie Watts; Raele Robison; Emily K Plowman
Journal:  Dysphagia       Date:  2016-02-02       Impact factor: 3.438

10.  Botulinum Toxin Is Effective in the Management of Neurogenic Dysphagia. Clinical-Electrophysiological Findings and Tips on Safety in Different Neurological Disorders.

Authors:  Enrico Alfonsi; Domenico A Restivo; Giuseppe Cosentino; Roberto De Icco; Giulia Bertino; Antonio Schindler; Massimiliano Todisco; Mauro Fresia; Andrea Cortese; Paolo Prunetti; Matteo C Ramusino; Arrigo Moglia; Giorgio Sandrini; Cristina Tassorelli
Journal:  Front Pharmacol       Date:  2017-02-22       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.